Comparative Efficacy of Aldosterone‐Related Sodium‐Retention Pathway Therapies for Resistant Hypertension: A Drug‐Level Network Meta‐Analysis of Randomized Controlled Trials
Mineralocorticoid receptor antagonists (MRAs), aldosterone synthase inhibitors (ASIs), and epithelial sodium channel (ENaC) blockade target different levels of the aldosterone‐related sodium‐retention pathway in resistant hypertension (RH), but the comparative efficacy of individual agents remains uncertain. We conduct...